Toll Free: 1-888-928-9744

Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2016

Published: Mar 11, 2016 | Pages: 95 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2016" provides an overview of Bronchopulmonary Dysplasia clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchopulmonary Dysplasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. 

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Bronchopulmonary Dysplasia to Respiratory Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Bronchopulmonary Dysplasia to Respiratory Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Bronchopulmonary Dysplasia Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Bronchopulmonary Dysplasia 31 Dec 08, 2015: Therabron Therapeutics Announces Favorable Infant Outcomes with Six-Month Follow-Up of a Phase 1b Recombinant Human CC10 Clinical Trial 31 Clinical Trial Profile Snapshots 32 Appendix 92 Abbreviations 92 Definitions 92 Research Methodology 93 Secondary Research 93 About GlobalData 94 Contact Us 94 Disclaimer 94 Source 95
List of Tables
Bronchopulmonary Dysplasia Therapeutics, Global, Clinical Trials by Region, 2016* 6 Bronchopulmonary Dysplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Bronchopulmonary Dysplasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14 Proportion of Bronchopulmonary Dysplasia to Respiratory Clinical Trials, G7 Countries (%), 2016* 15 Bronchopulmonary Dysplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Bronchopulmonary Dysplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Bronchopulmonary Dysplasia to Respiratory Clinical Trials, E7 Countries (%), 2016* 18 Bronchopulmonary Dysplasia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Bronchopulmonary Dysplasia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Bronchopulmonary Dysplasia Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Bronchopulmonary Dysplasia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Bronchopulmonary Dysplasia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Bronchopulmonary Dysplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30


List of Figures
Bronchopulmonary Dysplasia Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Bronchopulmonary Dysplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Bronchopulmonary Dysplasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13 Proportion of Bronchopulmonary Dysplasia to Respiratory Clinical Trials, G7 Countries (%), 2016* 15 Bronchopulmonary Dysplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Bronchopulmonary Dysplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Bronchopulmonary Dysplasia to Respiratory Clinical Trials, E7 Countries (%), 2016* 18 Bronchopulmonary Dysplasia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Bronchopulmonary Dysplasia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Bronchopulmonary Dysplasia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Bronchopulmonary Dysplasia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Bronchopulmonary Dysplasia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Bronchopulmonary Dysplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Bronchopulmonary Dysplasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 93

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likely

Read More...

Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Read More...

Global 3D scanning market is expected to be valued at USD 4,900.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing need for speedy and precise results with high efficiency is anticipated to drive the industry. 3D

Read More...

Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growt

Read More...

Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energ

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify